AU2001264789A1 - Protein powder for pulmonary delivery - Google Patents
Protein powder for pulmonary deliveryInfo
- Publication number
- AU2001264789A1 AU2001264789A1 AU2001264789A AU6478901A AU2001264789A1 AU 2001264789 A1 AU2001264789 A1 AU 2001264789A1 AU 2001264789 A AU2001264789 A AU 2001264789A AU 6478901 A AU6478901 A AU 6478901A AU 2001264789 A1 AU2001264789 A1 AU 2001264789A1
- Authority
- AU
- Australia
- Prior art keywords
- protein powder
- pulmonary delivery
- pulmonary
- delivery
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21042300P | 2000-06-08 | 2000-06-08 | |
US60210423 | 2000-06-08 | ||
PCT/US2001/016472 WO2001093837A2 (fr) | 2000-06-08 | 2001-05-31 | Poudre proteinique administree par voie pulmonaire |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001264789A1 true AU2001264789A1 (en) | 2001-12-17 |
Family
ID=22782843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001264789A Abandoned AU2001264789A1 (en) | 2000-06-08 | 2001-05-31 | Protein powder for pulmonary delivery |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001264789A1 (fr) |
WO (1) | WO2001093837A2 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1797902A3 (fr) * | 2000-12-29 | 2007-10-03 | Advanced Inhalation Research, Inc. | Particules à libération prolongée destinées à être inhalées |
DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
EP1734938B1 (fr) | 2004-03-26 | 2012-06-20 | Universita' Degli Studi Di Parma | Micro-particules a base d'insuline et hautement inhalables |
US7772182B2 (en) | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
WO2008130220A1 (fr) * | 2007-04-20 | 2008-10-30 | N.V. Nutricia | Procédé de dispersion d'acides aminés |
WO2009020434A1 (fr) * | 2007-08-07 | 2009-02-12 | Nanomaterials Technology Pte Ltd | Procédé de fabrication de particules de protéine microdimensionnée |
US9526764B2 (en) | 2008-10-17 | 2016-12-27 | Sanofi-Aventis Deutschland Gmbh | Combination of an insulin and a GLP-1-agonist |
US20100183876A1 (en) * | 2008-12-23 | 2010-07-22 | Hell Andre | Process for the Preparation of a Peptide Powder Form |
SI2498801T1 (en) | 2009-11-13 | 2018-06-29 | Sanofi-Aventis Deutschland Gmbh | A pharmaceutical composition containing desPro36Exendin-4 (1-39) -Lys6-NH2 and methionine |
EP3831402A1 (fr) | 2009-11-13 | 2021-06-09 | Sanofi-Aventis Deutschland GmbH | Composition pharmaceutique comprenant un agoniste du glp-1, une insuline et de la méthionine |
AU2010360116B2 (en) | 2010-08-30 | 2014-06-26 | Sanofi-Aventis Deutschland Gmbh | Use of AVE0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
WO2012171994A1 (fr) | 2011-06-15 | 2012-12-20 | Novo Nordisk A/S | Insulines à substitutions multiples |
MX370264B (es) | 2011-08-29 | 2019-12-09 | Sanofi Aventis Deutschland | Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2. |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
MX2017005692A (es) | 2014-10-31 | 2017-08-07 | Glaxosmithkline Ip Dev Ltd | Formulacion en polvo. |
ES2949095T3 (es) | 2014-12-12 | 2023-09-25 | Sanofi Aventis Deutschland | Formulación de relación fija de insulina glargina/lixisenatida |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
WO2018116300A1 (fr) * | 2016-12-22 | 2018-06-28 | Kamada Ltd. | Formulations de poudre sèche d'alpha-1 antitrypsine |
JP7410952B2 (ja) | 2018-12-21 | 2024-01-10 | ノヴォ ノルディスク アー/エス | Glp-1ペプチドの噴霧乾燥のプロセス |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4323636A1 (de) * | 1993-07-15 | 1995-01-19 | Hoechst Ag | Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung |
WO1996009814A1 (fr) * | 1994-09-29 | 1996-04-04 | Andaris Limited | Microparticules sechees par pulverisation utilisees comme excipient therapeutique |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
CA2341454A1 (fr) * | 1998-08-28 | 2000-03-09 | Benjamin Lee Hughes | Procede pour administrer des peptides insulinotropiques |
WO2000041682A1 (fr) * | 1999-01-18 | 2000-07-20 | Lg Chemical Limited | Microparticles lipophiles contenant un medicament ou un antigene proteique et preparation les contenant |
-
2001
- 2001-05-31 AU AU2001264789A patent/AU2001264789A1/en not_active Abandoned
- 2001-05-31 WO PCT/US2001/016472 patent/WO2001093837A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001093837A2 (fr) | 2001-12-13 |
WO2001093837A3 (fr) | 2002-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001264789A1 (en) | Protein powder for pulmonary delivery | |
AU2001232799A1 (en) | Protein c derivatives | |
AU2001233201A1 (en) | Dry powder inhaler | |
AU1409801A (en) | Powder inhaler | |
AU2002223028A1 (en) | Inhaler | |
AU6045900A (en) | Interaction-activated proteins | |
AU2001295483A1 (en) | Solid peptide preparations for inhalation, and the production thereof | |
AU2001232017A1 (en) | Pharmaceutical composition for pulmonary delivery | |
AU3201701A (en) | Pharmaceutical composition for pulmonary delivery | |
AU2002305903A1 (en) | Carbohydrate-associated proteins | |
AU2002239291A1 (en) | G protein coupled receptors | |
AU2001259450A1 (en) | Cytoskeleton-associated proteins | |
AU2001296389A1 (en) | Stable peptide formulations | |
AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
AU2001244863A1 (en) | Apoptin-associating protein | |
AU2001278975A1 (en) | Alpha-conotoxin peptides | |
AU2002357850A1 (en) | Neurotransmission-associated proteins | |
AU2001241044A1 (en) | Mitf-associated proteins | |
AU2001278777A1 (en) | Irap-binding protein | |
AU6444600A (en) | New protein | |
AU2001232068A1 (en) | Delivery capsules | |
AU7682600A (en) | Sildenafil preparation | |
AU2001263445A1 (en) | Methods for protein design | |
AU2001294911A1 (en) | Carbohydrate-associated proteins | |
AU2001277614A1 (en) | Novel proteins |